Alessio Ciulli, PhD
Alessio Ciulli holds the Personal Chair of Chemical Structural Biology at the School of Life Sciences, University of Dundee. He is the scientific founder of Amphista therapeutics, a biotech company spin-out of his Dundee laboratory that develops new protein degradation platforms. He is also the Founder and Director of Dundee’s new Centre for Targeted Protein Degradation, a new translational chemical biology center for innovating discoveries and next-generation therapeutics in the TPD field. Research in his laboratory focuses on developing small molecules inducing protein degradation and targeting protein-protein interactions. Ciulli’s lab has made crucial contributions in the TPD field, including the development of the VHL E3 ligase ligands and solving the first crystal structure of a PROTAC ternary complex.
Thursday 23rd March 13:30 h (CET time) / 12:30 h (UK time)
Log in to obtain the link